Back to top
more

Axon Enterprise (AXON)

(Delayed Data from NSDQ)

$281.67 USD

281.67
730,363

-0.06 (-0.02%)

Updated May 31, 2024 04:00 PM ET

After-Market: $281.35 -0.32 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (35 out of 250)

Industry: Security and Safety Services

Better trading starts here.

Zacks News

Resideo Technologies (REZI) Q1 Earnings and Revenues Beat Estimates

Resideo Technologies (REZI) delivered earnings and revenue surprises of 38.10% and 3.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Acco Brands (ACCO) Tops Q1 Earnings and Revenue Estimates

Acco (ACCO) delivered earnings and revenue surprises of 22.22% and 5.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Axon Enterprise (AXON) Q4 Earnings and Revenues Surpass Estimates

Axon (AXON) delivered earnings and revenue surprises of 187.50% and 7.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Axon Enterprise (AXON) Q4 Earnings Expected to Decline

Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Axon Enterprise (AXON) Surpasses Q3 Earnings and Revenue Estimates

Axon (AXON) delivered earnings and revenue surprises of 333.33% and 18.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Axon Enterprise (AXON) to Report a Decline in Earnings: What to Look Out for

Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JCI vs. AXON: Which Stock Is the Better Value Option?

JCI vs. AXON: Which Stock Is the Better Value Option?

Axon Enterprise (AXON) Q2 Earnings and Revenues Beat Estimates

Axon (AXON) delivered earnings and revenue surprises of 72.73% and 26.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Madhurima Das headshot

Industrial Stocks' Aug 5 Q2 Earnings Roster: BLL, AXON & More

A brief look at what factors might drive the Q2 results of stocks like Ball Corp (BLL), Axon Enterprise (AXON), Terminix Global (TMX), Resideo Technologies (REZI) and Alarm.com Holdings (ALRM).

Axon Enterprise (AXON) Reports Next Week: Wall Street Expects Earnings Growth

Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Axon Enterprise (AXON) Surpasses Q1 Earnings and Revenue Estimates

Axon (AXON) delivered earnings and revenue surprises of 47.62% and 17.72%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Axon Enterprise (AXON) Q1 Earnings Expected to Decline

Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Earnings Season Could Be Great for Axon Enterprise (AXON)

Axon Enterprise (AXON) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical

The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical

Nalak Das headshot

Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks

We have narrowed down our search to seven cyclical stocks that have popped more than 10% year to date and still have upside left for 2021. These are: DEN, CFG, GS, AXON, EMN, CAT and SMG.

Flowserve (FLS) to Report Q4 Earnings: What's in the Cards?

Flowserve's (FLS) Q4 earnings are likely to have gained from signs of recovery in end markets, solid backlog and cost-control actions. Low demand due to the pandemic might have marred its performance.

Ingersoll (IR) to Post Q4 Earnings: Is a Beat in the Cards?

Ingersoll Rand's (IR) Q4 earnings are likely to have gained from solid product portfolio, the Albin Pump buyout and cost-control actions. Unfavorable product mix might have marred its performance.

Axon Enterprise (AXON) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Allegion (ALLE) Surpasses Q4 Earnings and Sales Estimates

Allegion (ALLE) Q4 results reflect growth in sales and expansion in operating margin. Earnings for 2021 are predicted to decline year over year.

Allegion (ALLE) to Report Q4 Earnings: What's in the Cards?

Allegion's (ALLE) Q4 earnings are likely to have gained from solid product demand, strong residential business & healthy backlog. Low demand in Korea and Australia might have marred its performance.

ADT or AXON: Which Is the Better Value Stock Right Now?

ADT vs. AXON: Which Stock Is the Better Value Option?

iRobot (IRBT) to Report Q4 Earnings: What's in the Cards?

iRobot's (IRBT) Q4 earnings are likely to have gained from solid product demand, the holiday season and strong sales channels. However, high costs and expenses might have marred its performance.

II-VI (IIVI) to Report Q2 Earnings: What's in the Cards?

II-VI's (IIVI) Q2 earnings are likely to have gained from the solid product demand, the Finisar buyout and strong sales channels. However, high costs and expenses might have marred its performance.